Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

Share Price is delayed by 15 minutes
Get Live Data
221.80    -0.80 (-0.36%)
Bid:
221.60
Ask:
222.00
Spread: 0.40 (0.181%)
Market Cap: £2.27b
HTWS Live PriceLast checked at - London Stock Exchange

Intraday Helios Towers Share Chart

Conditional Redemption of Senior Notes

20 May 2024 08:15

RNS Number : 0664P
Helios Towers PLC
20 May 2024
 

This announcement contains inside information for the purpose of Article 7 of the Market Abuse Regulation (EU) 596/2014

NOT FOR DISTRIBUTION IN OR INTO ANY JURISDICTION OR TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION IN WHICH SUCH DISTRIBUTION IS UNLAWFUL

 

HELIOS TOWERS ANNOUNCES CONDITIONAL NOTICE OF REDEMPTION FOR ALL OF ITS OUTSTANDING 7.000% SENIOR NOTES DUE 2025

May 20, 2024 - HTA Group, Ltd (the "Issuer"), an indirect wholly owned subsidiary of Helios Towers plc (the "Company"), announces it has issued a conditional notice of redemption for all of its outstanding 7.000% Senior Notes due 2025 (the "Notes"). As set forth in the conditional notice of redemption issued today in respect of the Notes, the redemption date is June 18, 2024 (the "Redemption Date") unless the Redemption Date is delayed or revoked by the Issuer, and the redemption price for the Notes is 100.000% of the principal amount thereof, plus the amount of accrued and unpaid interest to, but excluding, the Redemption Date.

On the date hereof, the Issuer also announced (i) its offer to purchase for cash any and all of the Notes (the "Tender Offer") and (ii) an offering of new U.S. dollar-denominated senior notes subject to market conditions (the "New Notes Offering"). Any notes issued pursuant to the New Notes Offering and the guarantees in respect thereof have not been and will not be registered under the United States Securities Act of 1933. Neither the Tender Offer nor this announcement is an offer to sell or a solicitation of an offer to buy any notes issued pursuant to the New Notes Offering. No action has been or will be taken in any jurisdiction in relation to any notes issued pursuant to the New Notes Offering to permit a public offering of securities. This notice does not constitute an offer to sell, or a solicitation of an offer to buy, any security. No offer, solicitation, or sale will be made in any jurisdiction in which such an offer, solicitation or sale would be unlawful.

The redemption is subject to and conditioned upon the successful completion (in the sole determination of the Issuer) of the New Notes Offering.

Forward-Looking Information

Certain statements included herein may constitute forward-looking statements within the meaning of the securities laws of certain jurisdictions. Certain such forward-looking statements can be identified by the use of forward-looking terminology such as "believes", "expects", "may", "are expected to", "intends", "will", "will continue", "should", "would be", "seeks", "anticipates" or similar expressions or the negative thereof or other variations thereof or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of the Issuer concerning, among other things, the results in relation to operations, financial condition, liquidity, prospects, growth and strategies of the Issuer and the industry in which it operates. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future.

These forward-looking statements speak only as of the date of this announcement. The Issuer does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQBLBLZELXBBE
Date   Source Headline
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20252:34 pmRNSHolding(s) in Company
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 202512:30 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20253:21 pmRNSHolding(s) in Company
13th Nov 202511:24 amRNSHolding(s) in Company
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20251:04 pmRNSHolding(s) in Company
12th Nov 202511:31 amRNSDirector/PDMR Shareholding
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSResult of Secondary Placing in Helios Towers plc
10th Nov 20254:59 pmRNSStatement re Secondary Placing in Helios Towers
10th Nov 20254:47 pmRNSProposed Secondary Placing in Helios Towers plc
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20254:15 pmRNSHolding(s) in Company
6th Nov 20257:01 amRNSHelios Towers Share Buyback Programme
6th Nov 20257:01 amRNSHelios Towers Capital Markets Day
6th Nov 20257:00 amRNSHelios Towers 3rd Quarter Results
9th Oct 20257:00 amRNSNotice of Q3 2025 Results Date & CMD

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.